piracetam has been researched along with Polyneuropathies in 3 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Polyneuropathies: Diseases of multiple peripheral nerves simultaneously. Polyneuropathies usually are characterized by symmetrical, bilateral distal motor and sensory impairment with a graded increase in severity distally. The pathological processes affecting peripheral nerves include degeneration of the axon, myelin or both. The various forms of polyneuropathy are categorized by the type of nerve affected (e.g., sensory, motor, or autonomic), by the distribution of nerve injury (e.g., distal vs. proximal), by nerve component primarily affected (e.g., demyelinating vs. axonal), by etiology, or by pattern of inheritance.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of the present study was to investigate the protective effects of levetiracetam (LEV) on CIP in the early stage of sepsis in rats." | 7.79 | The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence. ( Akdemir, A; Erbaş, O; Ergenoğlu, AM; Peker, G; Taskiran, D; Yeniel, AÖ; Yilmaz, M, 2013) |
| " The aim of the present study was to investigate the protective effects of levetiracetam (LEV) on CIP in the early stage of sepsis in rats." | 3.79 | The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence. ( Akdemir, A; Erbaş, O; Ergenoğlu, AM; Peker, G; Taskiran, D; Yeniel, AÖ; Yilmaz, M, 2013) |
| "Levetiracetam is an anticonvulsant which is assumed to act by modulating neurotransmitter release via binding to the vesicle protein SV2A." | 2.76 | The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. ( Bach, FW; Holbech, JV; Jensen, TS; Otto, M; Sindrup, SH, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erbaş, O | 1 |
| Yeniel, AÖ | 1 |
| Akdemir, A | 1 |
| Ergenoğlu, AM | 1 |
| Yilmaz, M | 1 |
| Taskiran, D | 1 |
| Peker, G | 1 |
| Cai, X | 1 |
| Bhattacharyya, S | 1 |
| Plitt, A | 1 |
| Raibagkar, P | 1 |
| LaBuzetta, JN | 1 |
| Schleicher, SM | 1 |
| Munshi, NC | 1 |
| Klein, JP | 1 |
| Holbech, JV | 1 |
| Otto, M | 1 |
| Bach, FW | 1 |
| Jensen, TS | 1 |
| Sindrup, SH | 1 |
1 trial available for piracetam and Polyneuropathies
| Article | Year |
|---|---|
The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial.
Topics: Adult; Aged; Anticonvulsants; Cross-Over Studies; Double-Blind Method; Female; Humans; Levetiracetam | 2011 |
2 other studies available for piracetam and Polyneuropathies
| Article | Year |
|---|---|
The beneficial effects of levetiracetam on polyneuropathy in the early stage of sepsis in rats: electrophysiological and biochemical evidence.
Topics: Action Potentials; Animals; Antioxidants; Electromyography; Levetiracetam; Male; Malondialdehyde; Mu | 2013 |
Management of Posterior Reversible Encephalopathy Syndrome Induced by Carfilzomib in a Patient With Multiple Myeloma.
Topics: Anticonvulsants; Antihypertensive Agents; Antineoplastic Agents; Biomarkers, Tumor; Bortezomib; Brai | 2016 |